To our authors: The primary outcome measured in this trial was number of asthma exacerbations. Is it possible there are long term effects on frequency of asthmatic exacerbations beyond the timeline of the study, which was 48 weeks (under 1 year?) Would the data be different if patients were stratified according to age group, as the range extended from 12 months of 59 months of age?
Q&A has ended
Wanda Phipatanakul, MD, MS
Associate Professor of Pediatrics at Boston Children's Hospital / Harvard Medical School
Ian Paul, MD, MSc
Professor of Pediatrics and Public Health Sciences at Pennsylvania State University College of Medicine
William Sheehan, MD
Instructor of Pediatrics, Harvard Medical School at Boston Children's Hospital
Tzu-Ying Chuang, PhD
MD/PhD candidate at the University of Virginia.
- All Questions & Answers
- Question: Other clinical endpoints